1 Department of Clinical Neuroscience, Karolinska Institutet, Sweden.
Brain. 2014 Mar;137(Pt 3):770-8. doi: 10.1093/brain/awt356. Epub 2014 Jan 17.
Data on familial recurrence rates of complex diseases such as multiple sclerosis give important hints to aetiological factors such as the importance of genes and environment. By linking national registries, we sought to avoid common limitations of clinic-based studies such as low numbers, poor representation of the population and selection bias. Through the Swedish Multiple Sclerosis Registry and a nationwide hospital registry, a total of 28 396 patients with multiple sclerosis were identified. We used the national Multi-Generation Registry to identify first and second degree relatives as well as cousins, and the Swedish Twin Registry to identify twins of patients with multiple sclerosis. Crude and age corrected familial risks were estimated for cases and found to be in the same range as previously published figures. Matched population-based controls were used to calculate relative risks, revealing lower estimates of familial multiple sclerosis risks than previously reported, with a sibling recurrence risk (λs = 7.1; 95% confidence interval: 6.42-7.86). Surprisingly, despite a well-established lower prevalence of multiple sclerosis amongst males, the relative risks were equal among maternal and paternal relations. A previously reported increased risk in maternal relations could thus not be replicated. An observed higher transmission rate from fathers to sons compared with mothers to sons suggested a higher transmission to offspring from the less prevalent sex; therefore, presence of the so-called 'Carter effect' could not be excluded. We estimated the heritability of multiple sclerosis using 74 757 twin pairs with known zygosity, of which 315 were affected with multiple sclerosis, and added information from 2.5 million sibling pairs to increase power. The heritability was estimated to be 0.64 (0.36-0.76), whereas the shared environmental component was estimated to be 0.01 (0.00-0.18). In summary, whereas multiple sclerosis is to a great extent an inherited trait, the familial relative risks may be lower than usually reported.
关于多发性硬化等复杂疾病家族复发率的数据为病因因素提供了重要线索,例如基因和环境的重要性。通过链接国家登记处,我们试图避免基于诊所的研究的常见局限性,例如数量少、代表性差和选择偏倚。通过瑞典多发性硬化症登记处和全国性医院登记处,共确定了 28396 名多发性硬化症患者。我们使用全国多代登记处来确定一级和二级亲属以及表亲,并使用瑞典双胞胎登记处来确定多发性硬化症患者的双胞胎。对病例进行了粗略和年龄校正的家族风险估计,发现与以前发表的数字大致相同。使用匹配的基于人群的对照来计算相对风险,显示家族多发性硬化症风险的估计值低于以前报告的风险,同胞复发风险(λs=7.1;95%置信区间:6.42-7.86)。令人惊讶的是,尽管男性多发性硬化症的患病率较低,但母系和父系亲属的相对风险相等。因此,以前报道的母系亲属风险增加不能被复制。从父亲到儿子的传递率高于母亲到儿子的传递率表明,从患病率较低的性别向后代传递的风险更高;因此,不能排除所谓的“卡特效应”。我们使用已知的 74757 对同卵双胞胎和 250 万对同胞对的信息,其中 315 对患有多发性硬化症,来估计多发性硬化症的遗传性,以增加效力。遗传性估计为 0.64(0.36-0.76),而共享环境因素估计为 0.01(0.00-0.18)。总之,多发性硬化症在很大程度上是一种遗传性疾病,但家族相对风险可能低于通常报告的风险。